Aborvac R Sheep ((Brucella melitensis Rev1, injection Vaccine)
Aborvac R Sheep ((Brucella melitensis Rev1, injection Vaccine)

Aborvac R Sheep ((Brucella melitensis Rev1, injection Vaccine)

It is used to immunize 3-6 months old female - male lambs and kids and non-pregnant adult sheep and goats against brucellosis.

Composition:

ABORVAC-R SHEEP is an attenuated live lyophilized vaccine prepared from B. melitensis Rev1 vaccine strain. One dose of vaccine contains 1 - 2x105 (CFU) live bacteria. As a stabilizer in a 100-dose lyophilized vaccine: Enzymatic digest of Casein (Casiton) contains 6.25 mg, Sucrose 12.5 mg and sodium glutamate 2.5 mg.

Indications and Contraindications:

ABORVAC-R SHEEP vaccine is used for active immunilazition of female sheep and goat, older than 6 months aganist brucellosis.

Administration and Dosage:

  • Diluted the vaccine with sterile diluent, inject 1 ml s.c.
  • ABORVAC-R SHEEP Vaccine is made for healthy female - male lambs and kids and non-pregnant sheep and goats.
  • Vaccinated animals are marked with permanent marks.
  • It is recommended to keep the animals in a cool environment for 2 days after vaccination..

Warning:

The reconstituted vaccine should be used within 2 hours. Reconstituted vaccines not used with half or empty vaccine bottles should be buried deep in the soil after boiling for at least 5 minutes in water to prevent contamination.

Side effects:

In rare cases, in case of anaphylactic shock that may develop within 2 hours following vaccination, it should be given by subcutaneous route 10 times at 12 hours intervals from 1/5000 Atropine Sulfate solution.

Conditions of destruction Vaccines to be destroyed are inactivated in autoclave (30 minutes at 121 ° C) and discarded into the septic tank. In field conditions, the vaccine is buried deep in the ground after boiling for 5 minutes in a container with enough water in it.

Withdrawal Period:

Vaccinated animals should not be slaughtered after 3 months.

Storage Conditions:

The vaccine is stored in the dark environment and at +2 / + 8 ° C.

Presentation:

20, 50, 100 and 200 doses in vials with diluents. 

Veri politikasındaki amaçlarla sınırlı ve mevzuata uygun şekilde çerez konumlandırmaktayız. Detaylar için veri politikamızı inceleyebilirsiniz.